These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22539309)

  • 1. Cardiopulmonary assessment of patients with end-stage kidney disease.
    Arulkumaran N; Kumar N; Cecconi M; Banerjee D
    Nephrol Dial Transplant; 2012 Jul; 27(7):3000. PubMed ID: 22539309
    [No Abstract]   [Full Text] [Related]  

  • 2. Albuminuria and cardiovascular risk.
    Bogojevic Z; Bakris GL
    Heart Fail Clin; 2006 Jan; 2(1):53-9. PubMed ID: 17386876
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of myocardial scintigraphy in the assessment of cardiovascular risk in patients with end-stage chronic kidney disease on the waiting list for renal transplantation.
    Galvão De Lima JJ; Wolff Gowdak LH; de Paula FJ; Franchini Ramires JA; Bortolotto LA
    Nephrol Dial Transplant; 2012 Jul; 27(7):2979-84. PubMed ID: 22302207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elderly patients with chronic renal failure: what happens with global vascular prognosis?].
    Muñoz Rivas N; Méndez Bailón M
    Nefrologia; 2009; 29(5):486. PubMed ID: 19820764
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment.
    El Nahas M
    Nephron Clin Pract; 2010; 114(2):c103. PubMed ID: 20191694
    [No Abstract]   [Full Text] [Related]  

  • 6. ACE inhibitors and survival of hemodialysis patients.
    Efrati S; Zaidenstein R; Dishy V; Beberashvili I; Sharist M; Averbukh Z; Golik A; Weissgarten J
    Am J Kidney Dis; 2002 Nov; 40(5):1023-9. PubMed ID: 12407648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease.
    Chen SC; Chang JM; Liu WC; Huang JC; Tsai JC; Lin MY; Su HM; Hwang SJ; Chen HC
    Nephrol Dial Transplant; 2012 Mar; 27(3):1064-70. PubMed ID: 21813825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study.
    Bejan-Angoulvant T; Bergerot C; Juillard L; Mezergues A; Morelon E; Pouteil-Noble C; André-Fouët X; Angoulvant D
    Nephrol Dial Transplant; 2012 Jul; 27(7):2886-91. PubMed ID: 22344775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular disorders in chronic renal failure].
    Bagriĭ AE
    Ter Arkh; 1998; 70(11):80-3. PubMed ID: 9949472
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic strategies for heart failure in cardiorenal syndromes.
    House AA; Haapio M; Lassus J; Bellomo R; Ronco C
    Am J Kidney Dis; 2010 Oct; 56(4):759-73. PubMed ID: 20557988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin C; Nolin TD; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular problems on hemodialysis: current deficits and potential improvement.
    Ritz E; Bommer J
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S71-8. PubMed ID: 19996009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephropathy and metabolic heart diseases. Cardiac risk in kidney malfunction].
    MMW Fortschr Med; 2012 Aug; 154(14):70-1. PubMed ID: 22957461
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic kidney disease in older people; disease or dilemma?
    Ahmed AK; Brown SH; Abdelhafiz AH
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):835-41. PubMed ID: 20814116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of multidisciplinary pre-dialysis education in advanced chronic kidney disease: Propensity score matched cohort analysis.
    Cho EJ; Park HC; Yoon HB; Ju KD; Kim H; Oh YK; Yang J; Hwang YH; Ahn C; Oh KH
    Nephrology (Carlton); 2012 Jul; 17(5):472-9. PubMed ID: 22435951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentration of von Willebrand factor predicts mortality in patients on chronic renal replacement therapy.
    Péquériaux NC; Fijnheer R; Gemen EF; Barendrecht AD; Dekker FW; Krediet RT; Beutler JJ; Boeschoten EW; Roest M
    Nephrol Dial Transplant; 2012 Jun; 27(6):2452-7. PubMed ID: 22189209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease.
    Orskov B; Sørensen VR; Feldt-Rasmussen B; Strandgaard S
    Nephrol Dial Transplant; 2012 Apr; 27(4):1607-13. PubMed ID: 21873624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peritoneal dialysis and cardiopulmonary comorbidity].
    Wiesholzer M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():46-53. PubMed ID: 16437333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term retinal, renal and cardiovascular outcomes in diabetic chronic kidney disease without proteinuria.
    Agarwal R; Debella YT; Giduma HD; Light RP
    Nephrol Dial Transplant; 2012 Jan; 27(1):310-7. PubMed ID: 21669884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population.
    Oh SW; Baek SH; Kim YC; Goo HS; Heo NJ; Na KY; Chae DW; Kim S; Chin HJ
    Nephrol Dial Transplant; 2012 Jun; 27(6):2284-90. PubMed ID: 22140122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.